"We discovered a small amino acid sequence - we call it p10 because it is 10 amino acids long -- within the TSH receptor protein," Schöneberg explains. This sequence "functions as activator of the receptor upon binding of the hormone or autoantibodies."
In other words, the receptor itself flips the switch -- when it should and when it shouldn't.
The thoughts that come tumbling out from this... The fact that they seem to have established a fundamental mechanism. Perhaps it will answer my long-standing question about the impact of the glycosylation level of TSH? - that is something that varies but we have no real idea as to what impact is has.
Sadly, it will probably take the usual 14 or 17 or whatever it is years before it has even the slightest impact on clinical practice.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.